AI is fundamental to the competitive strategies of the most advanced healthcare and pharmaceutical firms. Here is how they ...

Investing at least part of the initial $1,000 in an artificial intelligence (AI) stock is a smart move. Despite impressive ...

The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data ...

Slashing adverse drug reactions through pharmacogenetics and advanced AI could help rehabilitate the pharmaceutical ...

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to ...

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) is among the fundamentally strong penny stocks to invest in. Analysts at H.C.

The pharmaceutical supply chain has entered a new era—one defined not just by compliance and safety, but by digital agility, ...

Argon AI Inc., the developer of an artificial intelligence-native workspace platform purpose-built for life sciences, today ...

The Verdict Recursion Pharmaceuticals offers a compelling investment for exposure to AI-driven drug discovery, backed by a strong balance sheet.

Rakovina Therapeutics Inc. ('Rakovina” or the 'Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next ...

The partnership will give Chugai access to Gero’s artificial intelligence technology to discover novel targets in ...